Literature DB >> 12180716

Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice.

Le Xuan Hai1, Toshiaki Kogure, Atsushi Niizawa, Hiroshi Fujinaga, Iwao Sakakibara, Yutaka Shimada, Hiroshi Watanabe, Katsutoshi Terasawa.   

Abstract

OBJECTIVE: To investigate the effect of hochu-ekki-to (HET) decoction on the development of collagen-induced arthritis (CIA) in mice.
METHODS: CIA was induced in male DBA/IJ mice by immunization with 2 injections of bovine type II collagen (CII). HET was orally administered at different doses and with different schedules. The incidence of arthritis, arthritis index, levels of anti-CII antibody, interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) and lymphocyte subsets were examined.
RESULTS: HET caused suppression of CIA development in a dose dependent fashion and exerted a suppressive effect on CIA when administered from the first CII immunization or from the onset of CIA, but not when administered for 2 weeks before CII immunization. HET inhibited the production of specific anti-CII antibody, IL-6, and TNF-alpha, and tended to normalize the proportions of cells in lymphocyte subsets.
CONCLUSION: HET suppresses the development of CIA, and HET redistributes the population of lymphocytes in lymph node and blood and inhibits IL-6 and TNF-alpha secretion in CIA mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12180716

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

1.  Preventive effect of Hochu-ekki-to on lipopolysaccharide-induced acute lung injury in BALB/c mice.

Authors:  Shunji Tajima; Masashi Bando; Hideaki Yamasawa; Shoji Ohno; Hiroshi Moriyama; Toshinori Takada; Eiichi Suzuki; Fumitake Gejyo; Yukihiko Sugiyama
Journal:  Lung       Date:  2006-11-03       Impact factor: 2.584

2.  The observation of humoral responses after influenza vaccination in patients with rheumatoid arthritis treated with Japanese oriental (kampo) medicine: an observational study.

Authors:  Toshiaki Kogure; Naoyuki Harada; Yuko Oku; Takeshi Tatsumi; Atsushi Niizawa
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-22       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.